The Animal Hyperbaric Oxygen Chamber market is primarily divided by application, which determines usage patterns and revenue distribution. Veterinary surgery accounts for the largest share, driven by the need for accelerated wound healing, infection control, and tissue regeneration in high‑value livestock and exotic species; this segment typically contributes around 40 % of total market volume. Equine rehabilitation follows, representing roughly 35 % of sales, as hyperbaric therapy is employed to treat musculoskeletal injuries, improve aerobic capacity, and reduce downtime for performance horses. The remaining 25 % is captured by companion animal therapy, where hyperbaric chambers are used for chronic conditions such as arthritis, skin disorders, and post‑operative recovery in dogs and cats. These application categories collectively shape the Animal Hyperbaric Oxygen Chamber segmentation, with each sub‑type influencing equipment specifications, pricing strategies, and regional adoption rates.